Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access               Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain DVAX message board posts where the ticker symbol DVAX has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest DVAX SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-061656 Size: 4 KB
8-K  Documents Current report, item 8.01
Acc-no: 0001564590-18-030292 (34 Act)  Size: 24 KB
2018-11-29 001-34207
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001564590-18-027411 (34 Act)  Size: 8 MB
2018-11-06 001-34207
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001564590-18-027396 (34 Act)  Size: 213 KB
2018-11-06 001-34207
8-K  Documents Current report, items 8.01 and 9.01
Acc-no: 0001193125-18-303690 (34 Act)  Size: 29 MB
2018-10-22 001-34207
SC 13G  Documents Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001144204-18-053466 (34 Act)  Size: 142 KB
2018-10-11 005-80035
8-K  Documents Current report, items 1.01, 1.02, and 2.03
Acc-no: 0001564590-18-023463 (34 Act)  Size: 28 KB
2018-09-21 001-34207
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001564590-18-019928 (34 Act)  Size: 6 MB
2018-08-07 001-34207
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001564590-18-019910 (34 Act)  Size: 280 KB
2018-08-07 001-34207
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-036802 Size: 4 KB
More DVAX SEC Filings

Related news from
Wed, 21 Nov 2018
00:51:58 +0000
Edited Transcript of DVAX earnings conference call or presentation 5-Nov-18 9:30pm GMT
Q3 2018 Dynavax Technologies Corp Earnings Call
Mon, 12 Nov 2018
20:37:00 +0000
Why Dynavax Technologies Corporation Fell 20.2% in October
Preliminary data that looked good on the surface left investors with more questions than answers.
Mon, 05 Nov 2018
22:39:18 +0000
Dynavax Technologies: 3Q Earnings Snapshot
The Berkeley, California-based company said it had a loss of 65 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
Mon, 05 Nov 2018
21:01:00 +0000
Dynavax Reports Third Quarter 2018 Financial Results, Progress on HEPLISAV-B Launch, and Updated SD-101 Data in Three Patient Populations
Conference Call to be held Today at 4:30pm ET/1:30pm PT BERKELEY, Calif., Nov. 05, 2018 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for.
Mon, 05 Nov 2018
20:00:00 +0000
Don't Waste Your Money on Penny Stocks; These 3 Stocks Are Better Buys
If you're looking for high-reward stocks, these three could pay off big.
Mon, 29 Oct 2018
10:00:00 +0000
Dynavax to Host Third Quarter 2018 Financial Results Conference Call
BERKELEY, Calif., Oct. 29, 2018 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it will report financial results for the third quarter ended September.
Fri, 26 Oct 2018
14:30:02 +0000
Dynavax Technologies (DVAX) Q3 Earnings Preview: What to Watch Ahead of the Release
Dynavax Technologies (DVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wed, 24 Oct 2018
12:41:12 +0000
Dynavax (DVAX) Catches Eye: Stock Jumps 9.8%
Dynavax (DVAX) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Mon, 22 Oct 2018
20:29:00 +0000
Why American Railcar Industries, PetMed Express, and Dynavax Technologies Jumped Today
Find out which of these companies got a buyout bid.
Mon, 22 Oct 2018
14:23:00 +0000
Why Dynavax Technologies Corporation Is Surging Today
Encouraging clinical data helps the beaten-down biotech to recover.
Sat, 20 Oct 2018
12:45:00 +0000
Dynavax’s SD-101 in Combination with KEYTRUDA® (pembrolizumab) Continues to Show a 70% Overall Response Rate in Advanced Melanoma Patients According to Data Presented Today at the ESMO 2018 Congress
- 70% overall response rate (33/47 patients) at 2 mg dose of SD-101 includes 17 additional patients - -Progression free survival, response rate in patients with PDL-1 negative.
Thu, 18 Oct 2018
15:05:00 +0000
Medical Companies You Need to Have on Your Radar
HENDERSON, NV / ACCESSWIRE / October 18, 2018 / Below are a few Medical stocks that are in position to make their investors major profit in the coming sessions.The company on our radar today, however, ...
Wed, 17 Oct 2018
11:20:00 +0000
Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis — Discovering Underlying Factors of Influence
NEW YORK, Oct. 17, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Mon, 15 Oct 2018
10:00:00 +0000
Dynavax Technologies and Quantum Leap Healthcare Collaborative Announce Selection of SD-101 Combined with KEYTRUDA® (pembrolizumab) in the I-SPY 2 TRIAL For Breast Cancer
Dynavax Technologies Corporation (DVAX) and Quantum Leap Healthcare Collaborative™ (QLHC) announced today that the immunotherapy combination of Dynavax’s proprietary investigational compound SD-101 and KEYTRUDA® (pembrolizumab) will be evaluated in a new randomized, investigational treatment arm for the ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer. SD-101 is expected to augment responses to anti-PD-1 therapy as has been reflected in early clinical studies of other tumor types.
Sun, 14 Oct 2018
17:21:15 +0000
The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs
Here are a few catalysts that can dictate the directional moves of biotech stocks in the upcoming week: Conferences European Society For Medical Oncology, or ESMO, 2018 Congress – Oct. 19-23, in Munich, ...
Wed, 10 Oct 2018
14:30:00 +0000
Major Biotech Announcements Moving the Market
HENDERSON, NV / ACCESSWIRE / October 10, 2018 / The biotech market is moved by events and announcements. There are a few major events currently impacting the companies highlighted below. Propanc Biopharma, ...
Tue, 09 Oct 2018
14:45:41 +0000
ARWR Stock Sinks After Signing a Big Collaboration Deal
On the charts, Arrowhead Pharmaceuticals (NASDAQ: ARWR) showed a “double top,” touching around $20 twice between September and October, before crashing down more than 30% in the last week. As value investors will ask after such a drop…what happened? On Oct. 4, Arrowhead announced that it entered into a license and collaboration with Janssen Pharmaceuticals, a unit of Johnson & Johnson (NYSE: JNJ).
Tue, 09 Oct 2018
10:00:00 +0000
Dynavax to Present New Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) at the European Society for Medical Oncology 2018 Congress
BERKELEY, Calif., Oct. 09, 2018 -- Dynavax Technologies Corporation (NASDAQ:DVAX) announced today that data will be presented from its ongoing Phase 1b/2 study investigating.
Wed, 03 Oct 2018
15:26:00 +0000
Why Dynavax Technologies Corporation Stock Struggled in September
Dynavax's shares kept losing ground last month, but a turnaround could be close at hand.

"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum is a great group of very smart, sophisticated investors. We have several professionals on board managing millions of dollars, and "average Joe" investors that beat the pants off of Wall Street professionals year in and year out. ValueForum will expose you to a wealth of ideas and sectors, and keep you ahead of the curve." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards